These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 20079591

  • 1. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.
    Phelip JM, Molinié F, Delafosse P, Launoy G, Trétarre B, Bara S, Buémi A, Velten M, Danzon A, Ganry O, Bouvier AM, Grosclaude P, Faivre J.
    Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
    Alter E, Phelip JM, Guilhot JN, Matysiak M, Vermorel M, Roblin X.
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.
    Winget M, Hossain S, Yasui Y, Scarfe A.
    Cancer; 2010 Oct 15; 116(20):4849-56. PubMed ID: 20578180
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant treatment for elderly patients with colon cancer. An observational study.
    Pasetto LM, Falci C, Basso U, Gasparini G, D'Andrea M, Bonginelli P, Bajetta E, Platania M, Alabiso O, Miraglia S, Bertona E, Oniga F, Biason R, Chetrì MC, Fedele P, Massara G, Romaniello I, Negru ME, Luchena G, Giordano M, Buzzi F, Ricottao R, Sienao S, Monfardini S.
    Anticancer Res; 2008 Oct 15; 28(4C):2513-8. PubMed ID: 18751443
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines.
    Abraham A, Habermann EB, Rothenberger DA, Kwaan M, Weinberg AD, Parsons HM, Gupta P, Al-Refaie WB.
    Cancer; 2013 Jan 15; 119(2):395-403. PubMed ID: 22806931
    [Abstract] [Full Text] [Related]

  • 6. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
    Zeig-Owens R, Gershman ST, Knowlton R, Jacobson JS.
    J Registry Manag; 2009 Jan 15; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
    [Abstract] [Full Text] [Related]

  • 7. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.
    Gibbs P, Handolias D, McLaughlin S, Chapman M, Johns J, Faragher I.
    Intern Med J; 2008 Apr 15; 38(4):265-9. PubMed ID: 18298558
    [Abstract] [Full Text] [Related]

  • 8. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM, Norwegian Gastrointestinal Cancer Group.
    Acta Oncol; 2009 Apr 15; 48(3):368-76. PubMed ID: 19242829
    [Abstract] [Full Text] [Related]

  • 9. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM.
    J Clin Oncol; 2004 May 15; 22(10):1797-806. PubMed ID: 15067028
    [Abstract] [Full Text] [Related]

  • 10. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH, Rapp T, Onukwugha E, Davidoff A, Choti MA, Gardner J, Seal B, Mullins CD.
    J Am Geriatr Soc; 2009 Aug 15; 57(8):1403-10. PubMed ID: 19563521
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG, Van Tinteren H, Zoetmulder FA, NACCP group.
    Br J Cancer; 2001 Nov 16; 85(10):1437-43. PubMed ID: 11720425
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST, Lee J, Park SH, Park JO, Lim HY, Kang WK, Kim JY, Kim YH, Chang DK, Rhee PL, Kim DS, Yun H, Cho YB, Kim HC, Yun SH, Lee WY, Chun HK, Park YS.
    Cancer Chemother Pharmacol; 2010 Sep 16; 66(4):659-67. PubMed ID: 20033812
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
    Benson AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG.
    J Clin Oncol; 2004 Aug 15; 22(16):3408-19. PubMed ID: 15199089
    [Abstract] [Full Text] [Related]

  • 16. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.
    Dis Colon Rectum; 2008 May 15; 51(5):503-7. PubMed ID: 18322753
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Adjuvant chemotherapy for colon adenocarcinoma in the county of Côte-d'Or].
    Jouve JL, Mitry E, Phelip JM, Villing AL, Tazi MA, Faivre J.
    Gastroenterol Clin Biol; 1998 Mar 15; 22(3):269-72. PubMed ID: 9762209
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.